Inozyme Pharma (INZY) Institutional Ownership

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)

Free INZY Stock Alerts

$4.60

-0.13 (-2.75%)

(As of 05/17/2024 06:55 PM ET)

Compare

Current Institutional Ownership Percentage: 88.30%
Number of Institutional Buyers (last 12 months): 19
Total Institutional Inflows (last 12 months): $50.65M

Number of Institutional Sellers (last 12 months): 10
Total Institutional Outflows (last 12 months): $17.63M

Get INZY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inozyme Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INZY Institutional Buying and Selling by Quarter

Ad The Freeport Society

Next President (Not Trump. Not Biden.)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.

Inozyme Pharma Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2024	California State Teachers Retirement System	4,799	$37K	0.0%	-38.9%	0.008%
5/16/2024	Kennedy Capital Management LLC	437,657	$3.35M	0.1%	+52.2%	0.708%
5/15/2024	Affinity Asset Advisors LLC	2,642,519	$20.24M	2.5%	+40.1%	4.272%
5/10/2024	Vanguard Group Inc.	2,419,020	$18.53M	0.0%	+1.4%	3.911%
5/7/2024	SG Americas Securities LLC	13,926	$107K	0.0%	-34.4%	0.023%
5/3/2024	GSA Capital Partners LLP	131,098	$1.00M	0.1%	-21.5%	0.212%
Get the Latest News and Ratings for INZY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Inozyme Pharma and its competitors with MarketBeat's FREE daily newsletter.
2/20/2024	Eventide Asset Management LLC	3,179,837	$13.55M	0.2%	+1.8%	5.149%
2/15/2024	Octagon Capital Advisors LP	400,000	$1.70M	0.3%	-69.2%	0.648%
2/14/2024	Superstring Capital Management LP	123,944	$528K	0.4%	N/A	0.201%
2/13/2024	Affinity Asset Advisors LLC	1,885,802	$8.03M	1.5%	+36.7%	3.053%
1/19/2024	Denali Advisors LLC	22,000	$94K	0.0%	-17.6%	0.036%
1/18/2024	Values First Advisors Inc.	13,898	$59K	0.0%	N/A	0.023%
1/12/2024	SG Americas Securities LLC	21,236	$90K	0.0%	+46.9%	0.034%
11/15/2023	Rock Springs Capital Management LP	3,681,174	$15.46M	0.4%	+7.4%	5.960%
11/15/2023	Laurion Capital Management LP	677,329	$2.85M	0.0%	+170.5%	1.097%
11/15/2023	Adage Capital Partners GP L.L.C.	5,537,500	$23.26M	0.1%	+30.3%	8.966%
11/15/2023	Affinity Asset Advisors LLC	1,379,852	$5.80M	1.6%	+83.5%	2.234%
11/14/2023	Eventide Asset Management LLC	3,125,000	$13.13M	0.2%	N/A	5.060%
11/14/2023	Schonfeld Strategic Advisors LLC	311,880	$1.31M	0.0%	+346.8%	0.505%
11/14/2023	Pivotal bioVenture Partners Investment Advisor LLC	4,494,851	$18.88M	7.5%	+22.8%	7.278%
11/13/2023	CHI Advisors LLC	1,270,027	$5.33M	1.6%	+6.3%	2.056%
11/13/2023	FMR LLC	2,465,232	$10.35M	0.0%	+229.2%	3.992%
11/7/2023	New York State Common Retirement Fund	13,375	$56K	0.0%	-21.8%	0.022%
10/26/2023	Strs Ohio	9,900	$41K	0.0%	N/A	0.016%
10/13/2023	SG Americas Securities LLC	14,452	$61K	0.0%	N/A	0.023%
9/21/2023	Barclays PLC	10,205	$56K	0.0%	+62.7%	0.017%
8/22/2023	CHI Advisors LLC	1,195,027	$6.66M	2.0%	-11.0%	1.936%
8/15/2023	Sphera Funds Management LTD.	1,131,967	$6.31M	1.0%	-36.5%	1.834%
8/14/2023	Deep Track Capital LP	1,644,021	$9.16M	0.4%	-49.4%	2.663%
8/14/2023	Rock Springs Capital Management LP	3,428,084	$19.09M	0.5%	+6.6%	5.553%
8/11/2023	Pivotal bioVenture Partners Investment Advisor LLC	3,661,518	$20.40M	6.7%	+13.9%	5.932%
8/7/2023	Acadian Asset Management LLC	57,468	$319K	0.0%	N/A	0.124%
8/4/2023	Parallel Advisors LLC	15,427	$86K	0.0%	-22.3%	0.033%
8/4/2023	American International Group Inc.	16,292	$91K	0.0%	N/A	0.035%
7/18/2023	Denali Advisors LLC	26,700	$149K	0.1%	N/A	0.061%
5/15/2023	Affinity Asset Advisors LLC	751,796	$4.31M	1.4%	+50.4%	1.718%
5/11/2023	CHI Advisors LLC	1,342,191	$7.69M	2.0%	-39.1%	3.067%
5/11/2023	Knott David M Jr	160,000	$917K	0.4%	N/A	0.366%
5/1/2023	Virtu Financial LLC	46,995	$269K	0.0%	N/A	0.107%
2/10/2023	NEA Management Company LLC	2,437,689	$2.56M	0.1%	-0.3%	6.035%
Shocking: One AI startup's revenue could surge 4,735% (Ad) Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner. Click here to discover the AI chip company
11/14/2022	UBS Oconnor LLC	165,498	$444K	0.0%	-3.4%	0.412%
8/16/2022	Deerfield Management Company L.P. Series C	2,696,372	$12.86M	0.3%	+15.0%	6.724%
8/15/2022	Laurion Capital Management LP	271,800	$1.30M	0.0%	+2,618.0%	0.678%
8/15/2022	Pivotal bioVenture Partners Investment Advisor LLC	2,661,154	$12.69M	6.4%	+67.2%	6.637%
8/11/2022	Bioimpact Capital LLC	664,980	$3.17M	0.9%	+125.4%	1.658%
8/11/2022	Overbrook Management Corp	69,326	$331K	0.1%	+314.5%	0.173%
8/8/2022	Walleye Capital LLC	101,442	$484K	0.0%	N/A	0.253%
2/15/2022	Laurion Capital Management LP	13,390	$91K	0.0%	-81.1%	0.057%
2/15/2022	Adage Capital Partners GP L.L.C.	1,599,028	$10.91M	0.0%	+8.9%	6.757%
2/14/2022	Suvretta Capital Management LLC	1,013,216	$6.91M	0.1%	+2.7%	4.281%
2/11/2022	Bioimpact Capital LLC	302,615	$2.06M	0.4%	-5.6%	1.279%
2/8/2022	Northern Trust Corp	120,762	$823K	0.0%	+4.0%	0.510%
2/2/2022	New York State Common Retirement Fund	3,834	$26K	0.0%	-63.3%	0.016%
11/16/2021	Suvretta Capital Management LLC	986,400	$11.43M	0.2%	+170.1%	4.168%
11/16/2021	Wellington Management Group LLP	364,600	$4.23M	0.0%	-50.0%	1.541%
11/16/2021	Laurion Capital Management LP	70,700	$819K	0.0%	N/A	0.299%
11/16/2021	BioImpact Capital LLC	320,724	$3.72M	0.6%	N/A	1.355%
11/16/2021	CHI Advisors LLC	920,264	$10.67M	3.1%	-0.8%	3.889%
11/15/2021	Deerfield Management Company L.P. Series C	2,344,786	$27.18M	0.5%	+7.6%	9.910%
11/15/2021	Rock Springs Capital Management LP	850,015	$9.85M	0.2%	+1.2%	3.592%
11/15/2021	Marshall Wace LLP	33,408	$387K	0.0%	-16.9%	0.141%
11/15/2021	Caas Capital Management LP	135,398	$1.57M	0.0%	N/A	0.572%
11/12/2021	Geode Capital Management LLC	198,624	$2.30M	0.0%	+10.5%	0.839%
11/8/2021	Russell Investments Group Ltd.	115,516	$1.34M	0.0%	+4,518.8%	0.488%
11/2/2021	New York State Common Retirement Fund	10,453	$121K	0.0%	+18.8%	0.044%
11/1/2021	SG Americas Securities LLC	11,611	$135K	0.0%	N/A	0.049%
8/25/2021	Marshall Wace LLP	40,202	$685K	0.0%	-22.4%	0.170%
8/17/2021	Millennium Management LLC	61,313	$1.05M	0.0%	-58.9%	0.259%
8/17/2021	Burrage Capital Management LLC	242,517	$4.13M	4.1%	+43.1%	1.025%
8/17/2021	Citadel Advisors LLC	171,066	$2.92M	0.0%	-28.8%	0.723%
8/16/2021	California State Teachers Retirement System	19,867	$339K	0.0%	+9.5%	0.084%
8/16/2021	Charles Schwab Investment Management Inc.	61,917	$1.06M	0.0%	+4.1%	0.262%
8/16/2021	State Street Corp	169,889	$2.90M	0.0%	+28.5%	0.718%
8/16/2021	Nuveen Asset Management LLC	47,394	$808K	0.0%	+122.6%	0.200%
8/16/2021	Goldman Sachs Group Inc.	19,310	$329K	0.0%	-18.8%	0.082%
8/16/2021	Marshall Wace LLP	40,202	$685K	0.0%	-22.4%	0.170%
8/13/2021	Northern Trust Corp	120,743	$2.06M	0.0%	+4.6%	0.514%
8/13/2021	Geode Capital Management LLC	179,672	$3.06M	0.0%	+19.5%	0.765%
8/13/2021	Vanguard Group Inc.	335,286	$5.71M	0.0%	-1.7%	1.428%
8/12/2021	JPMorgan Chase & Co.	16,659	$284K	0.0%	-21.9%	0.071%
8/11/2021	Bank of New York Mellon Corp	36,546	$623K	0.0%	+56.6%	0.156%
8/11/2021	BlackRock Inc.	899,873	$15.34M	0.0%	+4.4%	3.832%
8/10/2021	Citigroup Inc.	2,108	$36K	0.0%	+69.3%	0.009%
8/5/2021	Rhumbline Advisers	12,787	$218K	0.0%	N/A	0.054%
8/4/2021	Russell Investments Group Ltd.	2,501	$42K	0.0%	N/A	0.011%
8/2/2021	New York State Common Retirement Fund	8,802	$150K	0.0%	-28.4%	0.037%
5/18/2021	Millennium Management LLC	149,205	$2.95M	0.0%	N/A	0.635%
5/18/2021	Citadel Advisors LLC	240,401	$4.76M	0.0%	-4.8%	1.024%
5/18/2021	California State Teachers Retirement System	18,143	$359K	0.0%	+47.5%	0.077%
5/17/2021	Deerfield Management Company L.P. Series C	1,964,000	$38.89M	0.8%	+70.7%	8.363%
Shocking: One AI startup's revenue could surge 4,735% (Ad) Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner. Click here to discover the AI chip company
5/17/2021	Rock Springs Capital Management LP	827,900	$16.39M	0.4%	-0.3%	3.526%
5/17/2021	Suvretta Capital Management LLC	341,427	$6.76M	0.1%	+59.3%	1.454%
5/17/2021	Caas Capital Management LP	177,502	$3.52M	0.0%	N/A	0.756%
5/17/2021	Novo Holdings A S	1,969,379	$38.99M	1.6%	-23.4%	8.386%
5/17/2021	Goldman Sachs Group Inc.	23,790	$471K	0.0%	+14.2%	0.101%
5/13/2021	Bank of New York Mellon Corp	23,337	$462K	0.0%	+9.3%	0.099%
5/13/2021	Citigroup Inc.	1,245	$25K	0.0%	-44.3%	0.005%
5/12/2021	Northern Trust Corp	115,469	$2.29M	0.0%	+24.4%	0.492%
5/12/2021	Geode Capital Management LLC	150,361	$2.98M	0.0%	+41.3%	0.641%
5/12/2021	JPMorgan Chase & Co.	21,324	$422K	0.0%	+455.9%	0.091%

(Data available from 1/1/2016 forward)

INZY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of INZY shares?: During the previous two years, 34 institutional investors and hedge funds held shares of Inozyme Pharma. The most heavily invested institutionals were Adage Capital Partners GP L.L.C. ($23.26M), Affinity Asset Advisors LLC ($20.24M), Pivotal bioVenture Partners Investment Advisor LLC ($18.88M), Vanguard Group Inc. ($18.53M), Rock Springs Capital Management LP ($15.46M), Eventide Asset Management LLC ($13.55M), and Deerfield Management Company L.P. Series C ($12.86M).Learn more on INZY's institutional investors.
What percentage of Inozyme Pharma stock is owned by institutional investors?: 88.30% of Inozyme Pharma stock is owned by institutional investors. Learn more on INZY's institutional investor holdings.
Which institutional investors have been buying Inozyme Pharma stock?: Of the 25 institutional investors that purchased Inozyme Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($3.18M), Pivotal bioVenture Partners Investment Advisor LLC ($2.35M), Affinity Asset Advisors LLC ($2.14M), FMR LLC ($1.72M), Adage Capital Partners GP L.L.C. ($1.29M), Laurion Capital Management LP ($688.76K), and Rock Springs Capital Management LP ($466.27K).

How much institutional buying is happening at Inozyme Pharma?: Institutional investors have bought a total of 13,689,745 shares in the last 24 months. This purchase volume represents approximately $63.80M in transactions.
Which Inozyme Pharma major shareholders have been selling company stock?: Of the 12 institutional investors that sold Inozyme Pharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deep Track Capital LP ($1.61M), CHI Advisors LLC ($1.01M), Octagon Capital Advisors LP ($900K), Sphera Funds Management LTD. ($649.89K), GSA Capital Partners LLP ($35.91K), SG Americas Securities LLC ($7.31K), and NEA Management Company LLC ($6.69K).
How much institutional selling is happening at Inozyme Pharma?: Institutional investors have sold a total of 4,237,398 shares in the last 24 months. This volume of shares sold represents approximately $22.60M in transactions.

Related Companies:

This page (NASDAQ:INZY) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Inozyme Pharma (INZY) Institutional Ownership

INZY Institutional Buying and Selling by Quarter

Inozyme Pharma Major Shareholders & Ownership History

INZY Institutional Ownership - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Inozyme Pharma (INZY) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Inozyme Pharma (NASDAQ:INZY)

INZY Institutional Buying and Selling by Quarter

Inozyme Pharma Major Shareholders & Ownership History

INZY Institutional Ownership - Frequently Asked Questions